Bad News for Protozoa, Fungi and Bacteria
Posted on: Thursday, 21 August 2003, 06:00 CDT
Radioactive particles plus antibodies treat infectious disease
HealthDayNews -- In a research first, scientists at Albert Einstein College of Medicine successfully treated an infectious disease by piggy-backing radioactive particles onto antibodies, which zero in on disease-causing microbes without causing harm to healthy cells.
Radioimmunotherapy, which may offer a new way to fight diseases caused by a number of bacteria, fungi, protozoa and other organisms, uses ionizing radiation -- gamma rays or subatomic particles emitted by unstable isotopes. Ionizing radiation is an effective killer of microbes and gamma rays are routinely used to sterilize medical supplies and some foods.
In their study, the researchers affixed isotopes to antibodies and demonstrated that the microbe-killing ability of ionizing radiation can be harnessed for clinical use.
The study appears in the Aug. 18-22 issue of Proceedings of the National Academy of Sciences.
The researchers targeted their radioimmunotherapy against a major fungal pathogen called Cryptococcus neoformans. It can cause potentially fatal encephalitis in people with AIDS and others with weakened immune systems.
Mice were infected with the fungus and, a day later, the researchers injected them with varying concentrations of one or another of antibody preparations containing two different radioisotopes. Some other mice were infected with the fungus but not treated.
The mice treated with either of the radiolabeled antibodies lived much longer than untreated mice and suffered no apparent toxicity from the treatment. The study also found that, 48 hours after treatment, the mice treated with radioimmunotherapy had greatly reduced levels of fungi in their lungs and brains compared with untreated mice.
"These initial studies suggest that radioimmunotherapy could be a useful new antimicrobial weapon, with the potential for killing not only fungi but also other disease-causing microbes while causing few or no side effects," lead author Dr. Ekaterina Dadachova, an assistant professor of nuclear medicine, says in a news release.
-----
On the Net:
Infectious Disease information
Albert Einstein College of Medicine
More science, space, and technology from RedNova
Copyright © 2003 HealthDay. All rights reserved. The information contained above is intended for general reference purposes only. It is not a substitute for professional medical advice or a medical exam. Always seek the advice of your physician or other qualified health professional before starting any new treatment. Medical information changes rapidly and while Yahoo and its content providers make efforts to update the content on the site, some information may be out of date. No health information on Yahoo, including information about herbal therapies and other dietary supplements, is regulated or evaluated by the Food and Drug Administration and therefore the information should not be used to diagnose, treat, cure or prevent any disease without the supervision of a medical doctor.
Related Articles
- Mice Lead To Clues On Cause Of Epilepsy
- Peripheral Arterial Disease to Be Treated With New Medicated Stent in Trial at Montefiore
- Exciting Developments on the Horizon for Parkinson Disease, Says Medical Director for the National Parkinson Foundation
- More Insight into Alzheimer's Disease With Stanford Discovery of Possible Cause
- Drug Shows Promise Against Lou Gehrig's Disease, OK Medical Research Foundation Finds
- Quidel Corporation Appoints Renowned Leaders in the Diagnosis and Treatment of Infectious Disease to Medical Advisory Board
- Intercoastal Medical Group's Neurology Division Now Offers NovaVision VRT to Treat Vision Loss Caused By Stroke & TBI
- Tallahassee Memorial Rehabilitation Center Joins Medical Centers Across the United States Offering NovaVision VRT To Treat Vision Loss Caused By Stroke & TBI
- Washington County Hospital Joins Active Centers Across the United States Offering NovaVision VRT to Treat Vision Loss Caused By Stroke & TBI
- Proton-Pump Inhibitor Therapy for Gastroesophageal Reflux Disease: Does It Treat the Asthma?
User Comments (0)


RSS Feeds